Immunocap research assay to measure anti-drug antibodies to infliximab without acid dissociation

被引：0
|
作者：
Bergman, O. [1 ]
Grannas, K. [1 ]
Moverare, R. [1 ,2 ]
机构：
[1] Thermo Fisher Sci, Uppsala, Sweden
[2] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000939
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation
    Karsten, Carley
    Grannas, Karin
    Bergman, Oskar
    Moverare, Robert
    Roforth, Matthew
    Willrich, Maria Alice V.
    Snyder, Melissa R.
    Yang, Yifei K.
    AAPS JOURNAL, 2024, 26 (05):
  • [2] Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement
    Hamilton, R.
    Shields, S.
    MacDonald, J.
    Dunlop, A.
    Perry, M.
    McGucken, A.
    Gribben, E.
    Galloway, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S249 - S250
  • [3] ANTI-DRUG ANTIBODIES TO INFLIXIMAB: A COMPARISON OF FREE ANTI-DRUG ANTIBODY MEASUREMENT
    Hamilton, Rhona
    Shields, Stephanie
    Macdonald, Jonathan
    Dunlop, Allan
    Perry, Martin
    McGucken, Andrew
    Gribben, Elain
    Galloway, Peter
    GUT, 2021, 70 : A121 - A121
  • [4] InfliximabDeveloped anti-drug antibodies to infliximab: case report
    Reactions Weekly, 2018, 1714 (1) : 227 - 227
  • [5] Tolerating infliximab therapeutic drug monitoring without anti-drug antibodies - an argument for drug intolerant assays?
    Carlson, S.
    Evgeniou, V.
    Kok, K.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 894 - 895
  • [6] Cell sensitization to infliximab is detectable in a proportion of treated patients without anti-drug antibodies
    Nencini, F.
    Vultaggio, A.
    Pratesi, S.
    Maggi, E.
    Matucci, A.
    ALLERGY, 2015, 70 : 404 - 404
  • [7] anti-drug antibodies and the benefit of assay validation
    Little, Robert
    Sparrow, Miles P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (01) : 194 - 195
  • [8] Positivity thresholds of total infliximab and adalimumab anti-drug antibody assay: The prevalence of clearing and transient anti-drug antibodies in a national therapeutic drug monitoring service
    Nice, R.
    Chanchlani, N.
    Green, H.
    Bewshea, C.
    Kennedy, N.
    Ahmad, T.
    Goodhand, J.
    McDonald, T.
    Perry, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S018 - S019
  • [9] The temporal evolution of anti-drug antibodies in IBD patients treated with infliximab
    Ben-Horin, Shomron
    Ungar, Bella
    Chowers, Yehuda
    Yavzori, Miri
    Picard, Orit
    Fudim, Ella
    Eliakim, Rami
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 145 - 145
  • [10] Initial Clearance of infliximab is a predictor for the time of formation of anti-drug antibodies
    Kutschera, M.
    Primas, C.
    Reinisch, S.
    Novacek, G.
    Kim, S. H.
    Lee, S. H.
    Lee, J. H.
    Reinisch, W.
    Mould, D. R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S108 - S108
12345